- BNF:
- 4.8.1
- Status:
- Grey - after consultant/specialist initiation
- Decision Date:
- February 2017
Comments
GREY after consultant/specialist initiation and stabilisation for 3 months in patients that have responded to levetiracetam but unable to tolerate due to side effects.
Grey Drug Classifications
- 1: Lack of data on effectiveness compared with standard therapy
- 4: Lack of data on cost-effectiveness compared with standard therapy
- 5: Less cost-effective than current standard therapy
search again
